Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1999 Oct;52(5):269–274. doi: 10.1136/mp.52.5.269

Differential cytokine expression in EBV positive peripheral T cell lymphomas.

J W Ho 1, R H Liang 1, G Srivastava 1
PMCID: PMC395709  PMID: 10748876

Abstract

AIM: To investigate whether specific cytokines are secreted locally at the tumour site in Epstein-Barr virus (EBV) positive peripheral T cell lymphoma (PTCL). METHODS: An RNase protection assay system was used to study the differential expression of 21 cytokines in parallel in eight cases of EBV positive non-nasal PTCL, and compared with 11 EBV negative non-nasal PTCLs and three EBV positive nasal natural killer (NK) cell lymphomas. RESULTS: Among the eight EBV positive cases, interferon gamma (IFN-gamma), lymphotoxin beta (LT beta), interleukin 10 (IL-10), tumour necrosis factor alpha (TNF-alpha), transforming growth factor beta 1 (TGF-beta 1), and IL-1 receptor a (IL-Ra) were frequently detectable. IL-15, IL-6, IL-4, IL-1 beta, TNF-beta, and IL-9 were sporadically detectable. Of the frequently detectable cytokines, IFN-gamma and LT beta were commonly detected in the EBV negative cases. For cases with > 50% EBV encoded small non-polyadenylated RNA (EBER) positive cells, IL-10, TNF-alpha, and TGF-beta 1 were detected in three of three cases, and IL-1Ra in two of three cases. For cases with < 20% EBER positive cells, IL-10 was detected in three of five cases, TNF-alpha in two of four cases, but TGF-beta 1 and IL-1Ra were not detected. Interestingly, IL-6 was detected in two of three cases with > 50% EBER positive cells, but only in one of five cases with < 20% EBER positive cells. For comparison, in NK cell lymphomas, IL-10, TNF-alpha, IL-1Ra, and IL-6 were all detectable, but TGF-beta 1 was not detected at all. Immunohistochemical staining revealed IL-10 in many cells; in contrast, EBV latent membrane protein 1 (LMP1) was only found to be positive in isolated cells. CONCLUSIONS: Certain cytokines, such as IL-10 and TNF-alpha, might be expressed preferentially in EBV positive peripheral T cell lymphomas. It is likely that such a cytokine environment enhances EBV infection and contributes towards tumorigenesis.

Full Text

The Full Text of this article is available as a PDF (200.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad A., Menezes J. Binding of the Epstein-Barr virus to human platelets causes the release of transforming growth factor-beta. J Immunol. 1997 Oct 15;159(8):3984–3988. [PubMed] [Google Scholar]
  2. Altiok A., Jädersten M., Magyarlaki T., Klein E. Biphasic effect of transforming growth factor-beta on Epstein-Barr virus-induced activation of human tonsillar B cells. Immunol Lett. 1994 May;40(2):111–115. doi: 10.1016/0165-2478(94)90181-3. [DOI] [PubMed] [Google Scholar]
  3. Boulland M. L., Meignin V., Leroy-Viard K., Copie-Bergman C., Brière J., Touitou R., Kanavaros P., Gaulard P. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. Am J Pathol. 1998 Oct;153(4):1229–1237. doi: 10.1016/S0002-9440(10)65667-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carson W. E., Lindemann M. J., Baiocchi R., Linett M., Tan J. C., Chou C. C., Narula S., Caligiuri M. A. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood. 1995 Jun 15;85(12):3577–3585. [PubMed] [Google Scholar]
  5. Chan A. C., Ho J. W., Chiang A. K., Srivastava G. Phenotypic and cytotoxic characteristics of peripheral T-cell and NK-cell lymphomas in relation to Epstein-Barr virus association. Histopathology. 1999 Jan;34(1):16–24. doi: 10.1046/j.1365-2559.1999.00582.x. [DOI] [PubMed] [Google Scholar]
  6. Chiang A. K., Tao Q., Srivastava G., Ho F. C. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer. 1996 Nov 4;68(3):285–290. doi: 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Cossman J., Uppenkamp M., Sundeen J., Coupland R., Raffeld M. Molecular genetics and the diagnosis of lymphoma. Arch Pathol Lab Med. 1988 Feb;112(2):117–127. [PubMed] [Google Scholar]
  9. Foss H. D., Anagnostopoulos I., Herbst H., Grebe M., Ziemann K., Hummel M., Stein H. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood. 1995 May 15;85(10):2862–2869. [PubMed] [Google Scholar]
  10. Foss H. D., Herbst H., Hummel M., Araujo I., Latza U., Rancsò C., Dallenbach F., Stein H. Patterns of cytokine gene expression in infectious mononucleosis. Blood. 1994 Feb 1;83(3):707–712. [PubMed] [Google Scholar]
  11. Herbst H., Foss H. D., Samol J., Araujo I., Klotzbach H., Krause H., Agathanggelou A., Niedobitek G., Stein H. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood. 1996 Apr 1;87(7):2918–2929. [PubMed] [Google Scholar]
  12. Herbst H., Samol J., Foss H. D., Raff T., Niedobitek G. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J Pathol. 1997 Jul;182(3):299–306. doi: 10.1002/(SICI)1096-9896(199707)182:3<299::AID-PATH856>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  13. Ho F. C., Srivastava G., Loke S. L., Fu K. H., Leung B. P., Liang R., Choy D. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol Oncol. 1990 Sep-Oct;8(5):271–281. doi: 10.1002/hon.2900080505. [DOI] [PubMed] [Google Scholar]
  14. Ho J. W., Ho F. C., Chan A. C., Liang R. H., Srivastava G. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol. 1998 May;185(1):79–85. doi: 10.1002/(SICI)1096-9896(199805)185:1<79::AID-PATH52>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  15. Hsu S. M., Waldron J. W., Jr, Hsu P. L., Hough A. J., Jr Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol. 1993 Oct;24(10):1040–1057. doi: 10.1016/0046-8177(93)90183-h. [DOI] [PubMed] [Google Scholar]
  16. Kato H., Nagasaka T., Ichikawa A., Kinoshita T., Murate T., Tsushita K., Hotta T., Saito H. Tumor necrosis factor-beta gene expression and its relationship to the clinical features and histopathogenesis of peripheral T-cell lymphomas. Leuk Lymphoma. 1994 Dec;16(1-2):125–133. doi: 10.3109/10428199409114149. [DOI] [PubMed] [Google Scholar]
  17. Klein S. C., Kube D., Abts H., Diehl V., Tesch H. Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection. Leuk Res. 1996 Aug;20(8):633–636. doi: 10.1016/0145-2126(96)00029-x. [DOI] [PubMed] [Google Scholar]
  18. Lay J. D., Tsao C. J., Chen J. Y., Kadin M. E., Su I. J. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997 Oct 15;100(8):1969–1979. doi: 10.1172/JCI119728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Merz H., Fliedner A., Orscheschek K., Binder T., Sebald W., Müller-Hermelink H. K., Feller A. C. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol. 1991 Nov;139(5):1173–1180. [PMC free article] [PubMed] [Google Scholar]
  20. Merz H., Houssiau F. A., Orscheschek K., Renauld J. C., Fliedner A., Herin M., Noel H., Kadin M., Mueller-Hermelink H. K., Van Snick J. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood. 1991 Sep 1;78(5):1311–1317. [PubMed] [Google Scholar]
  21. Nakagomi H., Dolcetti R., Bejarano M. T., Pisa P., Kiessling R., Masucci M. G. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int J Cancer. 1994 Apr 15;57(2):240–244. doi: 10.1002/ijc.2910570218. [DOI] [PubMed] [Google Scholar]
  22. Raziuddin S., Abu-Eshy S., Sheikha A. Peripheral T-cell lymphomas. Immunoregulatory cytokine (interleukin-2, interleukin-4, and interferon-gamma) abnormalities and autologous mixed lymphocyte reaction. Cancer. 1994 Nov 15;74(10):2843–2849. doi: 10.1002/1097-0142(19941115)74:10<2843::aid-cncr2820741017>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  23. Rochford R., Cannon M. J., Sabbe R. E., Adusumilli K., Picchio G., Glynn J. M., Noonan D. J., Mosier D. E., Hobbs M. V. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol. 1997;10(4):183–195. doi: 10.1089/vim.1997.10.183. [DOI] [PubMed] [Google Scholar]
  24. Ross M. E., Caligiuri M. A. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood. 1997 Feb 1;89(3):910–918. [PubMed] [Google Scholar]
  25. Saed G., Fivenson D. P., Naidu Y., Nickoloff B. J. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J Invest Dermatol. 1994 Jul;103(1):29–33. doi: 10.1111/1523-1747.ep12388985. [DOI] [PubMed] [Google Scholar]
  26. Sappino A. P., Seelentag W., Pelte M. F., Alberto P., Vassalli P. Tumor necrosis factor/cachectin and lymphotoxin gene expression in lymph nodes from lymphoma patients. Blood. 1990 Feb 15;75(4):958–962. [PubMed] [Google Scholar]
  27. Shin S. S., Traweek S. T., Ulich T. R. Expression of interleukin-1 receptor antagonist protein in malignant lymphomas. An immunohistochemical study. Arch Pathol Lab Med. 1995 Mar;119(3):247–251. [PubMed] [Google Scholar]
  28. Su I. J., Kadin M. E. Expression of growth factor/receptor genes in postthymic T cell malignancies. Am J Pathol. 1989 Sep;135(3):439–445. [PMC free article] [PubMed] [Google Scholar]
  29. Suchi T., Lennert K., Tu L. Y., Kikuchi M., Sato E., Stansfeld A. G., Feller A. C. Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol. 1987 Sep;40(9):995–1015. doi: 10.1136/jcp.40.9.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tao Q., Ho F. C., Loke S. L., Srivastava G. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Int J Cancer. 1995 Jan 27;60(3):315–320. doi: 10.1002/ijc.2910600306. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES